SU006668 in Treating Patients With Advanced Solid Tumors
Status: UNKNOWN
Study type: INTERVENTIONAL
Conditions: Breast Cancer|Colorectal Cancer|Gastric Cancer|Kidney Cancer|Lung Cancer|Multiple Myeloma and Plasma Cell Neoplasm|Pancreatic Cancer|Prostate Cancer
Interventions: DRUG: orantinib
Sponsor: Jonsson Comprehensive Cancer Center
Collaborators: National Cancer Institute (NCI)